Angiotensin II

FDA-approved vasoconstrictor peptideEstablished

Angiotensin II is an FDA-approved vasoconstrictor peptide in the Angiotensin Receptor Agonist class. Angiotensin II binds the AT1 receptor on vascular smooth muscle, a Gq-coupled receptor whose activation raises intracellular calcium and produces vasoconstriction. It also stimulates aldosterone release and promotes renal sodium and water retention.

Calculate Dose

For research use only.

Key Facts

CAS
4474-91-3
Molecular Weight (MW)
1046.2 g/mol
Half-life
FDA status
Approved
Administration Route
intravenous
Frequency
Last updated
Aug 30, 2026
Reviewed
Aug 30, 2026

Research summary

Synthetic form of the endogenous octapeptide hormone, approved to raise blood pressure in adults with septic or other distributive shock.

Peptide Library's Angiotensin II profile summarises 5 cited studies listed in the Science section, the compound's regulatory status, and research-protocol parameters reported for it. It is a research reference, not medical advice.

Protocol

Dosage Range
Frequency
Cycle
Administration Route
intravenous
Reconstitution Guide

Not yet checked against primary sources

These figures are compiled from earlier reference material. They have not been verified against FDA labelling, registered trials or published literature, no citation is attached to them, and none of them is a recommended dose. Angiotensin II is queued for dosage evidence review.

Compare reported doses across the whole library

Sequence & molecular data

Sequence and molecular data for Angiotensin II
Amino acid sequenceAsp-Arg-Val-Tyr-Ile-His-Pro-Phe
Molecular formulaC50H71N13O12
Molecular weight1046.2 g/mol
CAS number4474-91-3
PubChem CID172198
FDA UNIIM089EFU921
ChEMBLCHEMBL408403
DrugBankDB11842

Identifiers link to the public PubChem, FDA Substance Registration (UNII), ChEMBL and DrugBank records for the same entity.

Science

Mechanism of Action

Angiotensin II binds the AT1 receptor on vascular smooth muscle, a Gq-coupled receptor whose activation raises intracellular calcium and produces vasoconstriction. It also stimulates aldosterone release and promotes renal sodium and water retention. Because it acts through a pathway independent of adrenergic receptors, it can raise blood pressure in shock states where catecholamine responsiveness is impaired.

Regulatory & research status

Angiotensin II is an FDA-approved product for specific labelled indications. Approval does not extend to the research contexts described on this page, and approved products are prescription medicines.

Regulatory and research status for Angiotensin II
FDA statusApproved
Research statusApproved product (see FDA status)
AvailabilityPrescription-Only
WADA (sport)Unknown / Not Listed
Library classificationFDA-Approved

Benefits

Potential Side Effects

No side effects listed yet for this entry.

Storage & stability

Lyophilized (freeze-dried) peptide powder is far more stable than the reconstituted solution. Keep sealed vials cold, dry and away from light; long-term storage is typically frozen, with short-term refrigeration for vials in use.

Once reconstituted in bacteriostatic water, keep the solution refrigerated, avoid repeated freeze–thaw cycles and agitation, and label the vial with the reconstitution date and concentration. Discard any solution that turns cloudy or shows particulates.

Degradation rates differ by sequence: peptides containing methionine, cysteine, asparagine or glutamine are more prone to oxidation and deamidation, so shelf life after reconstitution is compound-specific rather than universal.

Read the full guide: how to store peptides before and after reconstitution →

Source: Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544–575. (PMID 20143256). General guidance for research handling; not product-specific instructions.

Angiotensin II: frequently asked questions

What is Angiotensin II?

Synthetic form of the endogenous octapeptide hormone, approved to raise blood pressure in adults with septic or other distributive shock.

How does Angiotensin II work?

Angiotensin II binds the AT1 receptor on vascular smooth muscle, a Gq-coupled receptor whose activation raises intracellular calcium and produces vasoconstriction. It also stimulates aldosterone release and promotes renal sodium and water retention.

Is Angiotensin II FDA approved?

Yes. Angiotensin II is approved by the FDA, and approved products are prescription medicines. Approval is always for specific indications studied in clinical trials, so an approved status does not mean the compound is approved for every use it is discussed for. Research-chemical material sold under the same name is not the approved product.

What is the amino acid sequence of Angiotensin II?

Angiotensin II has the sequence Asp-Arg-Val-Tyr-Ile-His-Pro-Phe, giving a chain of 8 amino acids. Its molecular formula is C50H71N13O12.

What peptides are similar to Angiotensin II?

Compounds most often compared with Angiotensin II include Cetrorelix, Corticorelin, Cosyntropin and Degarelix. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

References

Related research, comparisons & guides

Related peptides

Compiled by Peptide Library Editorial · Reviewed Aug 30, 2026 · Updated Aug 30, 2026 · Version 1

This Angiotensin II profile is compiled from published literature (5 cited studies linked above), public regulatory records and chemical registries. It describes what research reports; it is not medical advice, and nothing here is a dosing recommendation for humans. Peptide Library does not sell peptides. Editorial policy · How profiles are compiled · Report an error

Track Angiotensin II research, inventory and reconstitution in the free Peptide Library app. Get the app for iOS or Android →